NCT06696768 2026-03-19Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal CancerNational Cancer Institute (NCI)Phase 1 Recruiting24 enrolled